on AMOEBA (EPA:ALMIB)
Amoéba Wins Gold at SIVAL for Biocontrol Innovation
Amoéba, a French greentech company, was awarded the gold medal at the SIVAL Innovation 2026 in Angers, France, for its biocontrol solution AXPERA. This recognition highlights their innovative approach to plant health, particularly against fungal diseases. Jean-François Doucet, CEO, expressed pride in this achievement, complementing past accolades like the Bernard Blum Award.
Amoéba has made strategic alliances, notably with Koppert, gaining exclusive distribution rights across Europe and the US for five years. They aim to launch the rebranded TIAGAN solution in nine European countries, pending regulatory approvals, targeting vineyards and vegetable crops.
In 2025, Amoéba saw considerable regulatory success, with European and US approvals for their biocontrol products. This, combined with a partnership with Syngenta, positions them well for market expansion. CNN's coverage in 2026 further underscores their innovative capabilities.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AMOEBA news